Ocriplasmin Recommended for Vitreomacular Adhesions

An advisory committee to the US Food and Drug Administration has voted to recommend ocriplasmin intravitreal injection for the treatment of symptomatic vitreomacular adhesions.
Medscape Medical News

Full Story →